All posts by medical

Mouse Brain Mapped in 3D, at High Resolution | ALZFORUM – Alzforum

13 May 2020

Behold the mouse brain, in glorious new detail. In the May 14 Cell, researchers led by Julie Harris and Lydia Ng at the Allen Institute for Brain Science in Seattle debut the third iteration of the Allen Mouse Brain atlas. Called the Common Coordinate Framework version 3 (CCFv3), this latest version takes advantage of high-resolution imaging techniques to produce a three-dimensional map of the entire brain at cellular-level anatomical detail. It also incorporates multiple types of gene expression, protein, and connectivity data to delineate each brain subregion. Researchers can import their own data into the atlas and use its common reference framework to compare their findings with those of other labs, Harris said.

This three-dimensional reference atlas is a true tour de force that will be hugely useful for the neuroscience community, Tara Spires-Jones at the University of Edinburgh wrote to Alzforum (full comment below).

The original Allen Reference Atlas (ARA), released in 2008, consisted of two-dimensional coronal and sagittal sections spaced every 200 m through the brain. Version 2, in 2011, converted this atlas into three dimensions by brute force, extrapolating what might lie between each section to achieve a resolution of 100 m.

See It Clearly. The third Allen Mouse Brain atlas used high-resolution imaging to draw a detailed three-dimensional map of brain structure. [Courtesy of Wang et al., Cell.]

For version 3, however, Allen researchers made use of serial two-photon tomography to map the entire mouse brain to a resolution of 10 m, 1,000-fold higher than the previous version. This resolution is in the range of neuronal cell bodies in the mouse brain, which vary in width from five to 20 m. The researchers imaged 1,675 young adult C57BL/6J mice and mathematically averaged the results into a single template. To their surprise, this iterative process heightened anatomical details, revealing fine features such as barrel formations in the somatosensory cortex (see "The Power of Averages" below). They were able to map the true three-dimensional geometry of the cortex, including the thick dendrites of layer V pyramidal neurons (see movie).

Joint first authors Quanxin Wang, Song-Lin Ding, and Yang Li then overlaid data from histology, immunohistochemistry, in situ hybridizations, transgene expression, and connectivity tracing to define brain subregions. They used nomenclature from the ARA and another classic two-dimensional mouse atlas, Paxinos and Franklins Mouse Brain in Stereotaxic Coordinates. This approach resulted in 658 individual named brain structures (see "A Brain Divided" below).

The Power of Averages. Averaging 1,675 mouse brains brought out fine structural details. [Courtesy of Wang et al., Cell.]

A Brain Divided. Multiple types of brain data allowed for the delineation of individual subregions. [Courtesy of Wang et al., Cell.]

All the data are freely available on the Allen Institute website. Harris encourages the research community to point out any discrepancies with existing data and submit new results to help refine and update the atlas.

This will no doubt be a useful teaching tool, in addition to its great utility to the research community, Michael Sasner at the Jackson Laboratory in Bar Harbor, Maine, wrote to Alzforum (full comment below). He collaborates with Harris on another project.Madolyn Bowman Rogers

View post:
Mouse Brain Mapped in 3D, at High Resolution | ALZFORUM - Alzforum

Brain Signal Analysis Software Market 2020: Prosperous Growth, Recent Trends and Demand by Top Key Vendors like Advanced Brain Monitoring, Applied…

Brain Signal Analysis Software MarketReport offers detailed insight, industry knowledge, market forecasts, and analytics. This market research studies aim to predict market size and future growth potential across sectors such as suppliers, industries and regions. This research report also combines industry-wide statistically relevant quantitative data and relevant and insightful qualitative analysis. Report also analyzes noteworthy trends, emerging value of CAGR and present as well as future development.

The report focuses on market contributions and provides a brief introduction, a business overview, revenue distribution, and product doses. This research report comprises exclusive and important factors that could have a noteworthy impact on the development of the global market during the forecast period of 2020-2027.

Ask for Sample of Report at https://www.qyreports.com/request-sample/?report-id=81039

Top Key Players:

Advanced Brain Monitoring, Applied Neuroscience, BESA, Brain Products, Compumedics, Guger Technologies, Natus Medical, Nihon Kohden, Persyst, Source Signal Imaging

Regional Analysis:

As the demand for new innovative solutions increases and more startups arise in the space which leads to growth and excessive demand for the Brain Signal Analysis Software Market in 2020 to 2027.This research report consists of the worlds crucial region market share, size (volume), trends including the product profit, price, Value, production, capacity, capability utilization, supply, and demand and industry growth rate.

Inquire For a Discount on Report at https://www.qyreports.com/ask-for-discount/?report-id=81039

Theglobal Brain Signal Analysis Software Market Reportanalyzes opportunities in the stakeholder market by identifying the high-growth sectors of the market. Identify key customers in the marketplace and comprehensively analyze key competencies such as new product launches.

Major Points Covered in Table of Contents:

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Complete Report is available at https://www.qyreports.com/enquiry-before-buying/?report-id=81039

About Us Qyreports:

We at, Qyreports, a leading market research report published accommodate more than 4,000 celebrated clients worldwide putting them at advantage in todays competitive world with our understanding of research. Our list of customers includes prestigious Chinese companies, multinational companies, SMEs and private equity firms whom we have helped grow and sustain with our fact-based research. Our business study covers a market size of over 30 industries offering unfailing insights into the analysis to reimagine your business. We specialize in forecasts needed for investing in a new project, to revolutionize your business, to become more customer centric and improve the quality of output.

Contact:

QYReports

Jones John

(Sales Manager)

204, Professional Centre,

7950 NW 53rd Street, Miami, Florida 33166

+1-510-560-6005

[emailprotected]

http://www.qyreports.com

See the article here:
Brain Signal Analysis Software Market 2020: Prosperous Growth, Recent Trends and Demand by Top Key Vendors like Advanced Brain Monitoring, Applied...

Lava Therapeutics and Janssen Biotech to Collaborate on Cancer Treatment Research – BioSpace

Lava Therapeutics announced on Friday that it has entered a research and license agreement with Janssen Biotech. The goal is to discover and develop novel bispecific antibodies to gamma-delta T cells for the treatment of cancer.

Under the terms of the agreement, Lava Therapeutics will perform discovery and product development activities. It will also be eligible to receive an undisclosed financial package made up of an upfront payment, as well as upfront and potential development and commercial milestones.

We are excited to enter into this collaboration with Janssen, a global innovator and leader in the development of new medicines, said Stephen Hurly, chief executive officer of Lava Therapeutics. We strongly believe in the strength of our bispecific gamma-delta T cell engager platform and are committed to creating highly potent, target-specific therapeutics with increased durability and safety over current T cell-based approaches.

This is not the first such agreement that a Johnson & Johnson company has entered as of late. Back in April, the Janssen Pharmaceutical Companies announced that it would be collaborating with Emergent BioSolutions to support the manufacturing of its lead investigational COVID-19 vaccine candidate.

Under the terms of the agreement, which was valued at about $135 million, Emergent agreed to provide drug substance manufacturing services. In addition, a long-term commercial manufacturing agreement is under negotiation for large-scale drug substance manufacturing.

When mission-driven organizations combine talents and capabilities, potential solutions to serious issues like COVID-19 become more within reach to benefit patients, said Robert G. Kramer Sr., president and chief executive officer of Emergent BioSolutions. We are proud of our collaboration with Johnson & Johnson and are equally committed to our longstanding relationship with the U.S. government. At a time like this, we all need to be working together to achieve maximum results for public health. Emergent is committed to our mission to protect and enhance life by advancing our own therapies and helping partner companies advance their programs as well.

In April, California-based Alveo Technologies also announced that it had entered a research collaboration agreement with Janssen Pharmaceuticals, Inc. The goal was to advance Alveos be.well platform of analyzers, nasal swabs and cartridges for the detection of viral infectious diseases, such as Respiratory Syncytial Virus (RSV). There was also the potential for the use of these products for the detection of COVID-19.

Under the collaboration agreement, Alveo received financial support, in addition to technical and regulatory counsel from Janssen relating to the regulatory submission of its be.well platform.

With be.well, we are talking about an entirely new approach to detect and help manage infectious diseases in individuals and populations, said Ron Chiarello, PhD, Founder, CEO and Chairman of the Board of Alveo. With a low-cost, easy-to-use device/app combination, we expect to have real-time diagnostic data to track and respond to disease outbreaks at a speed and scale that we could not have come close to previously. Janssens technical and regulatory support will help advance our platform, which we hope will empower people for the first time at home with on-demand infectious disease detection that may enable receiving treatment at the earliest possible time saving countless lives and medical resources and enabling global infectious disease surveillance on a scale, and at a speed, never seen before.

Janssen, which is headquartered in New Jersey, has been a part of the Johnson & Johnson family since 1961. It continues to focus on six therapeutic areas, including cardio and metabolism, immunology, infectious diseases and vaccines, neuroscience, oncology and pulmonary hypertension.

Read more here:
Lava Therapeutics and Janssen Biotech to Collaborate on Cancer Treatment Research - BioSpace

Tools for resiliency and de-stressing in the moment with HeartMath workshop – CU Boulder Today

Human Resources invites you to participate in HeartMath to learn how to de-stress, in the moment, during challenging situations. For over 20 years, the evidence-basedHeartMathprogram has helped people discover practical in the moment self-regulation tools to increaseresiliencyin stressful or pressured situations. This one-hour workshop will explain the role emotions play in performance and health. Participants will learn how to utilize the heart/brain connection to regulate heart rhythms to immediately address different emotional states in challenging situation. This program is based upon the Institute for HeartMaths research on physiology of optimal performance.

Date: Wednesday, May 27Time:1:00 to 2:00 p.m.Format: Zoom

Register

Erin Cunningham Ritter is the Director of Employee Engagement in the Deans Office, College of Arts and Sciences, University of Colorado. She previously served as the Director of Wellness Programs, Training and Leadership Development at the University of Colorado Anschutz Health and Wellness Center on the CU medical campus. For more than 15 years,Erinhas coached more than 3,000 clients on wellness, personal and professional development, allowing them to feel empowered to accomplish their unique goals.Erin is partnering with CU Boulder Human Resource to offer this workshop.

See the original post:
Tools for resiliency and de-stressing in the moment with HeartMath workshop - CU Boulder Today

Study links multitasking in workplace to negative emotions – Devdiscourse

Juggling from writing papers to answering calls, tackling all that at once at your workplace is not help, rather, it is likely to create a tense working environment followed by sadness and fear. According to the study's senior author Ioannis Pavlidis, director of Computational Physiology Laboratory at the University of Houston, "Not only do people experience stress with multitasking, but their faces may also express unpleasant emotions and that can have negative consequences for the entire office culture."

Pavlidis, along with Gloria Mark at the University of California Irvine, and Ricardo Gutierrez-Osuna at Texas A&M University, used a novel algorithm, based on co-occurrence matrices, to analyze mixed emotions manifested on the faces of so-called knowledge workers amidst an essay writing task. One group answered a single batch of emails before they began writing, thus limiting the amount of distraction, while the other group was frequently interrupted to answer emails as they came in.

The findings are published in the Proceedings of the 2020 CHI Conference on Human Factors in Computing Systems. "Individuals who engaged in multitasking appeared significantly sadder than those who did not. Interestingly, sadness tended to mix with a touch of fear in the multitasking cohort," Pavlidis said.

"Multitasking imposes an onerous mental load and is associated with elevated stress, which appears to trigger the displayed sadness. The simultaneous onset of fear is intriguing and is likely rooted to subconscious anticipation of the next disruption," he added. Because multitasking is a widespread practice, the display of these negative emotions can persist throughout the workday for many people. It is this ubiquitous, continuous and persistent character of the phenomenon that renders it such a dangerous 'climate maker', the researchers emphasized.

The facial expressions of the workers who answered emails in one batch remained mostly neutral during the course of their uninterrupted writing task. However, there was an element of anger during the separate email task, perhaps attributed to the realization of the amount of work needed to process all the emails in one session, the researchers theorize. The good news is that email batching is localized in time and thus its emotional effects don't last long. Solutions are possible in this case; the team suggests addressing the email batch at a later time when responding to emails is the only task, recognising that won't always be possible due to official pressure.

Negative displayed emotions - especially in open office settings - can have significant consequences on company culture, according to the paper. "Emotional contagion can spread in a group or workplace through the influence of conscious or unconscious processes involving emotional states or physiological responses." Upon return to normalcy following the COVID-19 crisis, the results suggest organizations should pay attention to multi-tasking practices to ensure a cohesive working environment.

"Currently, an intriguing question is what the emotional effect of multitasking at home would be, where knowledge workers moved their operation during the COVID-19 pandemic," said Pavlidis. The study was made possible by a 1.2 USD million grant from the National Science Foundation and is part of a series that examines multitasking behaviour among knowledge workers. (ANI)

See the original post:
Study links multitasking in workplace to negative emotions - Devdiscourse

American Chemical Society Student of the Year – Estes Park Trail-Gazette

Each year Estes Park High School gets to select the most outstanding Chemistry student to receive the American Chemical Society student of the year award. This year that honor goes to Meila Igel. She has worked hard all year, has maintained an almost perfect grade and has shown perseverance even through a cloud school setting. There is not a student more deserving of this award this year.

In a typical year the students and their families celebrate with a banquet and guest speaker and are presented a medal from ACS. With Covid-19, the in-person celebration didnt happen, but students were still recognized with their medals being mailed directly to them.

Meila is not only an outstanding student in Chemistry, but in all of her classes. She is also currently in Anatomy and Physiology and is again a phenomenal student in that class. Meila would like to pursue Medicine in her future. She still has one more year of high school and has not decided where she would like to go, but is leaning towards Grand Canyon University. She was the captain of the cross-country team this year and loves to hike in her Chacos. She loves cute dogs and a really good cup of coffee. Meila has so much potential to make a difference in the world. In times like today with our current pandemic I see students like Meila as a beacon of light towards the future. She is an amazing young woman and I am excited to see how she makes her mark on the world.

Written by: Pam Frey

See the original post:
American Chemical Society Student of the Year - Estes Park Trail-Gazette

Jesuit says goodbye to one of its longest-tenured faculty members – The Plank

After 43 years of working at Jesuit High School Sacramento, the 2019-2020 school year will be the last dance for Mr. Ross Evans.

First hearing of a job opportunity at the school from good friend and former teacher Mr. Gerry Campos, Mr. Evans began his career at Jesuit in 1977.

During his time at Jesuit, Mr. Evans served in a variety of roles. He taught Biology, Biology XL, Anatomy/Physiology, and Physical Education 1 and 2.

He was the physical education department chair for 42 years, coached track for 12 years, and football for 39 years. He also was the athletic director for five years and has been the assistant athletic director for the last 15 years.

In his more than four decades working at Jesuit, Mr. Evans has taught students and the children of those students.

Mr. Evans taught my father, brother, and now myself, said Hunter Cameron 21, a student in Mr. Evans Anatomy/Physiology class. My family has known Mr. Evans for quite a while, and I can confidently say not only is he a one-of-a-kind teacher, he is a great man.

Hes even taught and coached students who have gone on to become teachers at the school.

Mr. Evans was my biology teacher, and I eventually went on to be a biology major in college and later a science teacher, said Mr. Tom Witzgall 98, the science department chair and an assistant cross country coach.

English Teacher and Head Freshman Football Coach Mr. Phillip Nuxoll 83 was coached by Mr. Evans on the track and field team. Mr. Nuxoll remembers being less than enthusiastic about the sport when he first joined the team as a freshman, but that changed thanks to Mr. Evans.

I had no real interest in track at that time, but Coach Evans quickly changed that and made throwing the shot and disc some of my greatest memories during my four years as a student, Mr. Nuxoll said. He was a great technician on the field, and his knowledge of weight lifting and conditioning was unparalleled at the time, especially at the high school level. Most importantly, though, he made every one of his athletes feel like we were all contributors to the program and that we were all individually worth his time.

Students appreciate the passion and humor that Mr. Evans brings to teaching.

Coach Evans is a one-of-a-kind type of teacher, Hunter said. It is very clear the amount of dedication and love he has for teaching and his students. I feel as though he is not only a great, funny, and dedicated teacher, but he forms a great bond with all of his students.

Mr. Evans has also gained the respect of his fellow faculty members.

I have known Ross Evans for 11 years, said Spanish Teacher Ms. Sarah Kelso. He was one of the first people at Jesuit to become a friend because we bonded over our love for horses. Hes a real American hero in my eyes. A man who loves horses, who love[s] this country, who loves football, who loves Jesuit High Schooland [he] looks you in the eye, makes you feel seen, and makes you feel appreciated.

As his career comes to an end, Mr. Evans is thankful for all members of the Jesuit community.

Teaching at Jesuit has been a fulfillment of ones life, I could not imagine teaching and coaching anywhere else, Mr. Evans said. I am grateful for the entire Jesuit community. Jesuit is a special place, made that way by all who share in that community.

Its this love and gratitude for the Jesuit community that allowed Mr. Evans to have the impact he did on the students he taught, the athletes he coached, and the faculty and staff members he worked with.

While hes retiring from Jesuit, Mr. Evans wont stop being a fixture in the schools community anytime soon, as he plans to be a continued presence at many Jesuit events.

More here:
Jesuit says goodbye to one of its longest-tenured faculty members - The Plank

Regulation and dynamics of force transmission at individual cell-matrix adhesion bonds – Science Advances

Abstract

Integrin-based adhesion complexes link the cytoskeleton to the extracellular matrix (ECM) and are central to the construction of multicellular animal tissues. How biological function emerges from the tens to thousands of proteins present within a single adhesion complex remains unclear. We used fluorescent molecular tension sensors to visualize force transmission by individual integrins in living cells. These measurements revealed an underlying functional modularity in which integrin class controlled adhesion size and ECM ligand specificity, while the number and type of connections between integrins and F-actin determined the force per individual integrin. In addition, we found that most integrins existed in a state of near-mechanical equilibrium, a result not predicted by existing models of cytoskeletal force transduction. A revised model that includes reversible cross-links within the F-actin network can account for this result and suggests one means by which cellular mechanical homeostasis can arise at the molecular level.

Integrins are heterodimeric transmembrane proteins that form the core of micrometer-sized protein assemblies, here referred to generically as focal adhesions (FAs). These structures link the cytoskeleton to the extracellular matrix (ECM) and hence play a central role in the construction of multicellular tissues (13). Proteomics studies demonstrate that ~60 proteins constitute the core integrin adhesion machinery and that >2400 proteins are potential members of the integrin adhesome (4). Previous studies have uncovered a dense web of interactions between FA proteins (5), the complexity of which poses a challenge in understanding how FAs function as an integrated whole.

In this study, we sought to better understand how FA-mediated force transmission arises at the molecular level. The rationale in doing so is that the transmission of forces between the cytoskeleton and ECM constitutes a core function of FAs and is required both for tissue morphogenesis and many forms of cell migration. Force transmission is commonly described in terms of the molecular clutch model, in which continuous slippage between the rearward-flowing actin cytoskeleton and FA components mediates force transmission to the ECM (610). This model reproduces important biological observations, for example biphasic traction forces as a function of substrate stiffness (1113). However, to our knowledge, the clutch model has not been directly tested by the observation of the dynamics of force transmission at the single-molecule level in living cells.

We used fluorescence resonance energy transfer (FRET)based molecular tension sensors (MTSs) to measure the loads experienced by individual integrin heterodimers in human foreskin fibroblasts (HFFs) (Fig. 1, A to D). MTSlow and MTSFN910 report on loads between 2 and 7 pN and present either a linear arginine-glycine-aspartate (RGD) containing peptide or the fibronectin type III domains 9 and 10, respectively (14, 15). In addition, we developed a new sensor termed MTShigh that measures forces between 7 and 11 pN and contains the same RGD motif as MTSlow (fig. S1) (16). We found that HFFs had similar morphology, adhesion formation, and myosin activity when adhering to surfaces functionalized with either MTSlow or MTShigh (fig. S2).

(A) FRET-based MTSs. MTSs are attached to the coverslip surface via the HaloTag domain. (B) FRET-force calibration curves for MTSlow (blue) and MTShigh (purple) (16, 51). (C) Representative images showing green fluorescent protein (eGFP) (left), FRET donor (middle), and acceptor channels (right) for HFFs adhering to a surface functionalized with MTSlow. Scale bar, 5 m; inset scale bar, 2 m. (D) Example intensity traces (left) for the FRET donor (green) and acceptor (orange). Vertical dashed lines delineate frames during which the acceptor dye was directly excited with 633-nm light; arrows mark acceptor or donor bleaching; horizontal gray dashed lines indicate upper and lower force measurement limits. Right: Corresponding load time series before acceptor photobleaching (light blue). Intensity, arbitrary units (a.u.). (E) Single-molecule load distributions for MTShigh underneath cells, within adhesions, and outside adhesions. N = number of cells, n = number of sensors. (F) Combined single-molecule load distributions for MTSlow and MTShigh sensors underneath cells, within adhesions, and outside adhesions for MTSlow [blue; data from (14)] and MTShigh (purple).

In previous studies, we found that most ligand-bound integrins exist in a minimally tensioned state (<2 pN) that does not depend on the actin cytoskeleton (14), which we confirm in this study (Fig. 1E). Measurements using MTShigh further revealed that the distribution of loads on individual integrins was highly asymmetric, with a small minority of integrins within the adhesions of HFFs bearing loads of ~6 pN and >11 (Fig. 1, E and F). The presence of the latter subpopulation is consistent with previous studies demonstrating that at least some integrins experience peak loads >50 pN (1721).

How these different load subpopulations arise at the molecular level was unclear. A plausible explanation was that these subpopulations might correspond to ligation by different integrin heterodimers, a scenario supported by studies reporting distinct roles for 51- and v-class integrins in adhesion and traction generation (2225). To test this hypothesis, we made use of pan-integrin knockout (pKO) mouse kidney fibroblasts rescued with the integrin v subunit (pKO-v), which forms predominantly v3 and v5 heterodimers, the 1 subunit (pKO-1), which forms only 51 integrin in these cells, or both subunits (pKO-v/1), which form all three integrin heterodimers (22). pKO-v and pKO-v/1 cells spread normally on coverslips functionalized with either MTSlow or MTShigh and formed sizeable FAs (Fig. 2A, top and middle), while most of the pKO-1 cells failed to spread on either sensor (see insets). In contrast, all three cell types spread on coverslips functionalized with MTSFN910. However, pKO-v cells yielded lower integrated traction forces, without significant changes in adhesion size, compared to the other two cell types [Fig. 2, A (bottom), B, and D]. Thus, integrin usage and ligand identity strongly influenced adhesion and traction generation at the whole-cell level, an outcome consistent with previous observations (14, 24, 26, 27).

(A) Images of eGFP-paxillin and ensemble FRET maps for pKO-v, pKO-v/1, and pKO-1 cells adhering to MTSlow (top), MTShigh (middle), and MTSFN910 (bottom). Insets show corresponding bright-field images for pKO-1 cells, which rarely spread on surfaces functionalized with MTSlow and MTShigh. Scale bars, 10 m. (B) Ensemble quantification of pKO-v, pKO-v/1, and pKO-1 cells adhering to MTSlow, MTShigh, and MTSFN910. When adhering to MTSlow, pKO-v/1 cells exert more integrated traction compared to pKO-v cells (pKO-v: 67 cells, mean: 5.5 nN; pKO-v/1: 43 cells, mean: 9.8 nN) (***P = 3 104). When adhering to MTShigh, pKO-v/1 and pKO-v cells produce comparable traction overall (pKO-v: 77 cells, mean: 2.6 nN; pKO-v/1: 22 cells, mean: 7 nN). For MTSFN910, pKO-v/1 and pKO-1 cells exert a higher integrated traction as compared to pKO-v cells (pKO-v: 13 cells, mean: 7.9 nN; pKO-v/1: 12 cells, mean: 26.9 nN; pKO-v/1: 12 cells, mean: 23.8 nN) (***P < 10 to 3). (C) Single-molecule load distributions for pKO cell lines adhering to MTSFN910. Black bars indicate unbound molecules. (D) Adhesion area measured for pKO-v, pKO-v/1, and pKO-1 cells adhering to MTSFN910. Areas were calculated from the thresholded eGFP-paxillin signal. Differences in adhesion area were not significant between the three cell types.

We next measured the distribution of loads experienced by individual integrins for pKO-v, pKO-1, and pKO-v/1 cells adhering to coverslips functionalized with MTSFN910. Contrary to expectation, the distributions of loads for integrins bearing >2 pN were notably similar across all three cell lines (Fig. 2B and fig. S3). However, the fraction of integrin-bound sensors underneath cells was significantly higher for pKO-v/1 and pKO-1 cells as compared to pKO-v cells (Fig. 2C and table S1), a factor that can largely account for the differences in traction generation at the whole-cell level. Thus, integrin usage indirectly influenced overall cellular traction by modulating the fraction of engaged integrins but did not influence the distribution of loads borne by individual, ligand-bound integrins.

An alternate hypothesis was that the load experienced by an integrin, regardless of class, is determined by the nature of its linkages to the actin cytoskeleton. The cytosolic protein vinculin reinforces the talin-actin linkage and may influence the load borne by individual integrins. We quantified traction generation at the whole-cell and single-integrin level for wild-type (WT) and vinculin-null (vin/) mouse embryonic fibroblasts (MEFs) adhering to MTSlow and MTShigh (Fig. 3, A and B) (28). WT but not vin/ MEFs generated appreciable regions with low FRET when adhering to MTShigh (Fig. 3B), indicating that vinculin was required for the subpopulation of integrins transmitting loads >7 pN (Fig. 3C). This observation was likewise borne out by the distribution of loads on single integrins (Fig. 3D). Thus, linkages to F-actin, but not integrin heterodimer type, helped to determine the loads transmitted by individual integrins.

(A) Ensemble FRET maps for WT and vin/ MEFs transfected with eGFP-paxillin and seeded on coverslips functionalized with MTSlow and MTShigh sensors. Scale bar, 10 m. (B) Total integrated traction per cell for forces <7 pN measured with MTSlow. Open circles indicate the mean value. (WT: 96 cells, mean: 3.6 nN; vin/: 89 cells, mean: 4.4 nN.) (C) Total integrated traction per cell for forces between 7 and 11 pN measured with MTShigh. Open circles indicate the mean. (WT: 71 cells, mean: 8.7 nN; vin/: 99 cells, mean: 1.5 nN.) (D) Histograms of the single-molecule load measurements for WT and vin/ MEFs measured for cells adhering to MTSlow for sensors outside adhesions (left) and within adhesions (right). ***P < 0.001 using two-sided Wilcoxon rank sum test.

We next examined the dynamics of force transmission at individual MTSs (Fig. 4). A large subpopulation of MTSlow and MTSFN910 yielded close-to-constant FRET levels corresponding to measurable loads <2 pN (Figs. 1D and 4). As noted above, we attribute this subpopulation to integrins that experience low loads that are independent of the cytoskeleton, for example, due to glycocalyx compression (29). In addition, we observed MTSlow, MTSFN910, and MTShigh sensor molecules that experienced loads consistent with cytoskeletally generated forces (>2 pN for MTSlow and MTSFN910; >7pN for MTShigh). Of these, most remained bound for up to tens of seconds at a close-to-constant force (Figs. 1D and 4B and table S2). This observation is in apparent contradiction with previous formulations of the clutch model, which predict continuous load-and-fail dynamics stemming from the progressive loading and failing of connections to F-actin (fig. S5). A minority of MTS FRET traces did exhibit anticorrelated changes in FRET donor and acceptor intensities indicative of dynamic changes in load (table S3 and figs. S6 to S8). We have classified these as either step (close to instantaneous at our time resolution of ~1 s) or more gradual ramp transitions (Fig. 4, A and C, and table S4). Although the clutch model predicts ramp increases and step decreases in load, it does not predict the step increases or ramp decreases in load that we observed (figs. S6 to S8). Although we cannot exclude the possibility that a subset of these events may be due to dye blinking, we rarely observe these events in our no-load control measurements (table S5). Measurements in U2OS osteosarcoma cells, which have been extensively used in studies of cell migration (30), did not show step or ramp transitions (fig. S9). Thus, dynamic changes in load, at least as assayed here, were evidently dispensable for cell adhesion.

(A) Representative traces showing step (left) and gradual ramp (right) load transitions (FRET donor: green; FRET acceptor: orange; load: blue) for HFFs adhering MTSlow. Black arrows mark acceptor or donor bleaching; dashed black lines indicate direct excitation of the FRET acceptor. Horizontal gray dashed lines indicate upper and lower force measurement limits for MTSlow. (B) Percentage low force (defined as <2 for MTSlow or < 7 pN for MTShigh) (blue), higher force but static (green), and dynamic (hashed; subset of loaded integrins) sensors for a variety of cell types adhering to different MTSs. (C) Percent of dynamic sensors with step (magenta) and ramp (purple) transitions. U2OS cells had no observable dynamic events.

Our observations prompted us to explore extensions of the clutch model that incorporated known aspects of the architecture of FAs and the actin cytoskeleton. In established versions of the clutch model, all the F-actin filaments move with the same instantaneous velocity, which scales inversely with the total tension summed over all clutches (12). Individual clutches undergo repeated cycles of loading and failure as the monolithic F-actin moves rearward (fig. S5). We explored multiple extended models that included multiple clutch-actin connections, akin to multiple vinculins linking talin to actin, viscous relaxation of the clutch, catch bond behavior, or reversible actin cross-linkers (see Model Comparisons in the Supplementary Materials and Fig. 5). Among the models examined, only the addition of reversible cross-links between actin filaments (e.g., by -actinin, filamin, nonmuscle myosin II, or other cross-linkers), yielded long periods of close-to-constant loads analogous to those observed in single-molecule measurements (Fig. 5, A to C). This result reflected the establishment of temporary mechanical equilibria between discrete clusters of motors (e.g., nonmuscle myosin II) and clutches (talin and vinculin). In addition, simulations recapitulated occasional step transitions, which reflected the disconnection or reattachment of an individual clutch to an actin filament, and ramp transitions, whose time scale reflected the equilibration of loads within the cross-linker network.

(A) Simplified cartoon of a FA: Nonmuscle myosin II pulls on reversibly cross-linked actin filaments, which are linked to integrins by vinculin and talin. (B) Cytoskeletal dynamics model: F-actin filaments bind to anchors (blue) and are linked by cross-linking proteins (green). (C) An example force trace of the standard clutch model and possible clutch model extensions that account for multivalent clutch connections, viscous relaxation, or reversible cross-links. Reversible cross-links allow for stable force plateaus as well as sporadic ramp and step events. The dashed gray lines indicate zero force. (D) Calculated energy dissipation from simulations with irreversible (top) and reversible (bottom) cross-links. (E) Force distribution for simulated anchors with reversible cross-linking (kx,off = 20 s1).

Besides the addition of cross-linker binding and release rates [based on those of -actinin (31)], the model required only minor tuning compared to a previously published clutch model (8). In contrast, irreversible cross-links between F-actin, as well as other clutch model extensions, resulted in load-and-fail dynamics, analogous to previous clutch models (Fig. 5C). These load-and-fail cycles are predicted to be costly in terms of energy dissipated in the repeated stretching of individual anchor linkages: In line with this understanding, models featuring reversible cross-linker dynamics predicted lower energy dissipation for similar overall force levels (Fig. 5D). Simulations performed with low substrate stiffnesses produced similar load dynamics (fig. S10). This result reflects the use of a clutch rupture force (Fb; table S6) that is larger than the typical load borne by an individual clutch linkage, a choice in parameterization that was necessary to reproduce the long-lived binding events that we observe (Figs. 1 and 4). It is possible that the dynamics and force sensitivity of the clutch connection to F-actin may differ in different cell types, and possibly in different compartments of the cell, for example, in nascent adhesions versus stable FAs.

The above model describes the loads borne by individual linkages to F-actin rather than by the integrins themselves. However, the anchor force distributions for simulations with reversible cross-linkers qualitatively match the observation of a peak in the measured load distributions for MTSlow and MTShigh (Figs. 5E and 1, E and F). Talin contains three actin binding sites and can recruit up to 11 vinculin molecules (32, 33). It is plausible that these connections to F-actin act in parallel, resulting in a broad range of loads transmitted by individual integrins. This possibility is supported by our observation of distinct subpopulations of integrins bearing ~6 and >11 pN within the FAs of HFFs (Fig. 1F), potentially reflecting multiple connections to F-actin. Single-pN loads are broadly consistent with a report that the average load experienced by talin was <6 pN (34). However, previous reports also describe >11-pN loads for a subset of talin molecules (35) and peak loads of >50 pN for a subset of integrins (21); these higher loads likely reflect additional, vinculin-mediated connections to F-actin (Fig. 3, A and C). In total, these observations are consistent with the hypothesis that the addition of multiple linkages to F-actin can result in a wide range of loads on individual integrins.

Actin retrograde flow rates provide an independent means of testing cytoskeletal clutch models (8, 12, 24). To examine how the simulated actin velocities compared with our system, we measured the velocity of F-actin filaments by treating living HFFs with 50 nM SiR-actin, a fluorogenic small-molecule probe that binds to F-actin. The mean speed for F-actin within both adhesions and linear F-actinrich structures (e.g., stress fibers) was 7.9 nm/s (95% confidence interval: 7.6-8.1 nm/s; 9 cells, 2355 tracks), comparable to the mean velocity of 5 nm/s observed in reversible cross-linker simulations. These measured and simulated velocities are approximately one-half to one-third the magnitude of F-actin speeds measured in the lamellipodia of Xenopus XTC cells, respectively, differences that may reflect a decrease in F-actin velocities near adhesions (36).

Previously, we found that most of the integrins exist in a minimally tensioned state (14). Here, we extend this result and report that a small fraction of ligand-engaged integrins support loads >11 pN. The large majority of integrins thus experience loads substantially less than their maximum capacity. This mechanical reserve may allow cells to withstand external stresses that would threaten tissue integrity. Conversely, the ability to exert large, localized forces via a few integrins may be essential for cell migration and mechanosensing, for example, in fibrous ECM networks, where local effective stiffnesses can span several orders of magnitude (37, 38). Integrin complexes thus represent an interesting example of how a highly asymmetric distribution of activity at the molecular level (here, force transmission) can yield flexible and robust functionality at the cell and tissue levels.

Contrary to expectation, most of the integrins experienced close-to-constant loads within the resolution of our measurements (10). Although several nonexclusive factors, for example, domain unfolding in talin (33), may contribute to this observation, a model that incorporates reversible cross-links in the F-actin cytoskeleton is sufficient to account for our observations. This model is consistent with reports demonstrating that -actinin cross-linking activity can change the mechanical properties of F-actin networks (39) and influence cell migration and traction force generation (40), although multiple actin cross-linkers are likely to contribute. Force transmission through a network of dynamic cross-linkers also reduced energy consumption compared to a system that underwent repeated load-and-fail cycles (Fig. 5D). We suggest that, despite the complexity of adhesion complexes, cellular mechanical homeostasis and efficient force transmission may arise from the core dynamical properties of the cytoskeleton. Additional tests in other model systems will, however, be required to establish the generality of this supposition.

Our data imply that the chain of molecular linkages between individual tension sensors and F-actin can remain stable for tens of seconds even under appreciable loads (Figs. 1 and 4 and table S2). This observation, in turn, suggests that the load on individual clutch linkages is, on average, appreciably less than their characteristic Fb (table S6). In the modified clutch model, this parameterization predicts adhesions whose stability is relatively insensitive to substrate stiffness (fig. S10). In contrast, adhesions with smaller Fb, or equivalently a higher average load per clutch, are predicted to yield load-and-fail dynamics at individual clutches and sensitivity to substrate stiffness as predicted in the original clutch model (8, 12). Determining whether the force sensitivity of adhesions differs as a function of cell type, matrix properties, and/or adhesion maturation provides an important target for future work. We speculate that modulation of key parameters such as the average load per clutch may provide a potent yet flexible method for cells to change mechanical states in response to external stimuli.

A core result of systems biology is that cellular subsystems, for example, signal transduction pathways, are often organized into semiautonomous functional modules, an outcome thought to enhance both robustness and evolvability (41, 42). Although previously proposed (5), whether a similar functional modularity might apply to complex structural assemblies such as FAs has been unclear. Our observations suggest that, despite a dense web of protein-protein interactions (43), FAs maintain modularity at a functional level. In the model systems studied here, the force-transducing machinery linking F-actin to adhesions resulted in per-integrin load distributions that were essentially identical regardless of integrin heterodimer usage (Fig. 2C). Integrin heterodimer usage in turn determined both ligand specificity and adhesion stability and, hence, influenced cellular adhesion and traction output. The flexibility afforded by this modular organization is likely to have greatly facilitated the evolution of the remarkable functional diversity of integrin-based adhesion complexes in metazoans.

Our findings complement work demonstrating that some proteins are recruited to FAs as part of preassembled complexes (4446), suggestive of a hierarchical assembly process. These preassembled protein complexes are, however, not necessarily synonymous with single, defined functions; in other systems, evolutionary data demonstrate that biological function is often preserved even when the protein(s) fulfilling that function are not (47). Compositional and functional modularity may thus constitute distinct, and complementary, principles that govern the form and function of complex macromolecular assemblies.

MTSlow and MTSFN910 were prepared as previously described (14, 15). The high-force MTS (MTShigh) was adapted from MTSlow by replacing the (GPGGA)8 module with another tension-sensitive domain, termed HPst (LSDED FKAVF GMTRS AFANL PLWKQ QALMK EKGLF), derived from the villin headpiece (16). The DNA encoding this construct was assembled by Epoch Life Sciences Inc. (Missouri City, TX) and was cloned into the pJ414 expression vector (DNA 2.0). We used Alexa 546 maleimide (Thermo Fisher Scientific, A10258) as the FRET donor and an Alexa 647 maleimide dye (Thermo Fisher Scientific, A20347) as the FRET acceptor. This modified MTS presents the identical RGD ligand derived from fibronectin as used in MTSlow. The entire MTShigh sequence is presented below:

M G S E I G T G F P F D P H Y V E V L G E R M H Y V D V G P R D G T P V L F L H G N P T S S Y V W R N I I P H V A P T H R S I A P D L I G M G K S D K P D L G Y F F D D H V R F M D A F I E A L G L E E V V L V I H D W G S A L G F H W A K R N P E R V K G I A F M E F I R P I P T W D E W P E F A R E T F Q A F R T T D V G R K L I I D Q N V F I E G T L P M G V V R P L T E V E M D H Y R E P F L N P V D R E P L W R F P N E L P I A G E P A N I V A L V E E Y M D W L H Q S P V P K L L F W G T P G V L I P P A E A A R L A K S L P N A K A V D I G P G L N L L Q E D N P D L I G S E I A R W L S T L E I S G G A G E F K C A G L S D E D F K A V F G M T R S A F A N L P L W K Q Q A L M K E K G L F G K C A G S E N L Y F Q G T V Y A V T G R G D S P A S S A A H H H H H H.

Sensors were expressed in BL21(DE3) competent Escherichia coli. Cultures (500 ml) were grown overnight at 30C with ampicillin (100 g/ml) and induced with 1 mM isopropyl--d-thiogalactopyranoside at an optical density of 0.6. The bacteria were then spun down at 6000g for 30 min and resuspended in 10 ml of lysis buffer [50 mM sodium phosphate, 300 mM NaCl, and 10 mM imidazole, (pH 8)] with a protease inhibitor cocktail (11873580001, Roche) and 10 M lysozyme. The resuspended cells were rocked for 30 min at 4C, lysed with a tip sonicator, and spun at 14,000g for 30 min. The supernatant was incubated with 2 ml of nickelnitrilotriacetic acid HisPur Resin (Thermo Fisher Scientific) and rocked at 4C for 2 hours. The solution was then packed into a gravity column, washed three times with 5 ml of wash buffer [50 mM sodium phosphate, 300 mM NaCl, and 20 mM imidazole (pH 7.4)], and incubated with 4 ml of elution buffer [50 mM sodium phosphate, 300 mM sodium chloride, and 250 mM imidazole (pH 7.4)] for 5 min. The eluate was collected and dialyzed overnight into storage buffer [1 phosphate-buffered saline (PBS), 1 mM EDTA, and 2 mM -mercaptoethanol], flash-frozen, and stored at 80C. Fractions were characterized by SDSpolyacrylamide gel electrophoresis (SDS-PAGE), and the concentration was determined by ultravioletvisible (UV-Vis) spectroscopy (fig. S1).

Labeling of MTSs was performed through dual cysteine labeling and subsequent purification to separate the population of sensors with a single donor and acceptor dye. The cysteines were first reduced with 2 mM tris(2-carboxyethyl)phosphine for 30 min at room temperature and buffer exchanged into labeling buffer [50 mM phosphate buffer, 150 mM NaCl, and 1 mM EDTA (pH 7.4)] using three 7K Zeba desalting columns (89883, Thermo Fisher Scientific) in series. Alexa 546 and Alexa 647 maleimide dyes were added at a protein:donor:acceptor ratio of 1:1.5:2 for 1 hour at room temperature and overnight at 4C. To help remove free dye and exchange the protein into fast protein liquid chromatography (FPLC) buffer A [50 mM tris buffer (pH 8) and 5 mM -mercaptoethanol], the solution was passed through two PD MiniTrap desalting columns (45001529, GE Healthcare) in series. To separate out the sensors with a single donor and single acceptor, we used an AKTA Pure FPLC (GE Healthcare) with a MonoQ PC 1.6/5 (GE Healthcare) ion exchange column and a 10 mM/ml linear salt gradient with buffer B [50 mM tris (pH 8), 5 mM -mercaptoethanol, and 2 M NaCl]. Fractions were characterized using SDS-PAGE, UV-Vis spectroscopy, and single-molecule imaging. The desired fractions were concentrated and exchanged into PBS using 3K centrifugal filters (Amicon) and stored at 80C.

Coverslips were prepared as previously described (14). Briefly, 24 mm by 50 mm no. 1 coverslips (Fisherbrand) were sonicated in a bath sonicator (Kendall) for 20 min with isopropanol, Milli-Q water, and 5 M KOH, with Milli-Q water rinses between each step. The coverslips were then sonicated for 5 min in methanol and transferred to a solution of 2-ml N-(2-aminoethyl)-3-aminopropyltrimethoxysilane (97%) (A0700, UCT Specialties), 10-ml glacial acetic acid, and 200-ml methanol. The coverslips were incubated in the silane mixture for 10 min, sonicated for 1 min, and then incubated for another 10 min. They were then rinsed with Milli-Q water and dried with nitrogen. To passivate the coverslips, 100 mg of maleimide polyethylene glycol (PEG) succinimidyl carboxymethyl ester (molecular weight, 5000; A5003-1, JenKem Technology) was dissolved in 1 ml of 100 mM phosphate buffer (pH 7.0). Two coverslips were sandwiched with 100 l of the PEG solution in between for 1 hour at room temperature and protected from light. The coverslips were then washed with Milli-Q water and dried before being incubated overnight with 100 l of 3 mM Halo ligand thiol (P6761 Promega or AcmeBiosciences Inc.) in 100 mM phosphate buffer (pH 7.0). Afterward, the coverslips were washed with Milli-Q water, dried, and stored in vacuum-sealed bags at 20C.

Flow chambers were attached to PEGylated coverslips as previously described (15). For ensemble experiments, chambers were prepared with 100 nM double-labeled sensor and incubated at room temperature for 30 min. For the single-molecule assay, 100 nM unlabeled sensor with 100 pM labeled sensor was mixed in PBS and added to the flow cells for 30 min. The chambers were then washed with 200 l of PBS and Pluronic F-127 (0.2% w/v) for ~1 min to prevent nonspecific cell attachment. The chambers were washed again with PBS to remove excess Pluronic. Cells were then added and incubated for at least 1 hour at 37C in Dulbeccos modified Eagles medium (DMEM) high-glucose medium. FRET measurements were made within 3 hours of plating the cells and acquired with an objective heater (Bioptechs) set to 37C. Images were prepared in Fiji (48) and analyzed using custom MATLAB scripts.

For immunofluorescence, cells were fixed with 4% paraformaldehyde for 15 min at 37C and washed with PBS. Cells were then permeabilized with 0.1% Triton X-100 in PBS for 5 min, washed with PBS, and then blocked with 5% bovine serum albumin (BSA) for 1 hour at room temperature. Antibodies for myosin IIa (Sigma-Aldrich, no. M8064; 1/100 dilution) and phosphorylated myosin light chain (Cell Signaling Technologies, no. 3675S; 1/200 dilution) were incubated with 5% BSA for 45 min at room temperature. Secondary antibodies (anti-rabbit 647, Cell Signaling Technologies, no. 4414S; and anti-mouse 555, Cell Signaling Technologies, no. 4409S; 1/200 dilution) were incubated with 5% BSA for 45 min at room temperature.

Single-molecule and ensemble FRET fluorescence measurements were performed with objective-type total internal reflection fluorescence (TIRF) microscopy on an inverted microscope (Nikon TiE) with an Apo TIRF 100 oil objective lens, numerical aperture 1.49 (Nikon) as described previously (14) and controlled using Micromanager (49). Samples were excited with 473-nm OBIS laser (Coherent), 532-nm (Crystalaser), or 635-nm (Blue Sky Research) lasers. For single-molecule data, emission for the FRET donor and emission channels were separated as previously described and recorded on an electron-multiplying charge-coupled device camera (Andor iXon) (15). For collection of the green fluorescent protein (GFP) signal, we used an additional set of emission filters mounted on a motorized flip mount (Thorlabs Inc.) placed the donor fluorescence emission path. Filters used included a 593/40 nm filter (Semrock Inc.) for the collection of donor emission, a 675/30 nm filter for the collection of acceptor emission, and a 514/30 nm filter (Semrock Inc.) for GFP emission collection. For ensemble FRET maps taken for whole cells, emitted light passed through a quad-edge laser-flat dichroic with center/bandwidths of 405/60 nm, 488/100 nm, 532/100 nm, and 635/100 nm from Semrock Inc. (Di01-R405/488/532/635-2536) and corresponding quad-pass filter with center/bandwidths of 446/37 nm, 510/20 nm, 581/70 nm, 703/88 nm band-pass filter (FF01-446/510/581/703-25). GFP, donor, and acceptor images were taken through separate additional cubes stacked into the light path (GFP: 470/40 nm, 495 nm long-pass, and 525/50 nm; donor: 550 nm long-pass; acceptor: 679/41 nm and 700/75 nm) and recorded on a Hamamatsu Orca Flash 4.0 camera.

HFF cells CCD-1070Sk (American Type Culture Collection CRL-2091) were cultured in DMEM high-glucose medium (Gibco, catalog no. 21063-029) in the absence of phenol red and supplemented with 10% fetal bovine serum (FBS; Axenia Biologix LLC ), sodium pyruvate (1 mM, Gibco), MEM nonessential amino acids (1; Gibco), and penicillin/streptomycin (100 U/ml and 100 g/ml; Gibco), herein referred to as normal culture medium. The cells were grown at 37C with 5% CO2. Fibroblasts with stably expressing eGFP-paxillin (fused at the C terminus) were prepared as previously described (15).

pKO mouse kidney fibroblasts rescued with either v, 1, or both v and 1 integrin subunits were a gift from R. Fssler (Max Planck Institute Martinsried) (22). Cells were cultured on fibronectin-coated plastic (5 g/ml; Corning, diluted in PBS and incubated at 37C for 1 hour) in normal culture medium described above. pKO-1 cells in particular were sensitive to the quality of fibronectin coating; thus, a minimum of 1 and 4 ml of the diluted fibronectin solution (5 g/ml) were used per well for a six-well and 10-cm dish, respectively. Cells were grown at 37C with 5% CO2.

WT and vin/ MEFs were a gift from K. Rothenberg and B. Hoffman (Duke University) (28). Cells were cultured on tissue culture plastic in normal culture medium at 37C and 5% CO2.

U2OS cells were a gift from M. Franklin and J. Liphardt (Stanford University). Cells were cultured on tissue culture plastic in normal culture medium at 37C and 5% CO2.

pKO-integrin cells and WT and vinculin KO MEF cells were transfected using a similar protocol to the one previously described for eGFP-paxillin human fibroblasts (15). Cells were trypsinized, pelleted, resuspended in medium lacking FBS and penicillin/streptomycin, and counted. pKO-integrin cells (2 106) and WT (5 105) and vinculin KO cells were repelleted at 800 rpm for 10 min. P4 Nucleofector solution (82 l) was added to 18 l of P4 supplement in a 1.5-ml Eppendorf tube and used to resuspend the cell pellet. DNA for C-terminal eGFP-paxillin (Addgene, no.15233) cloned into the DNA 2.0 PiggyBac vector (~4 g) was added to the cells and gently flicked before transferring to a Lonza nucleofection cuvette. Cuvettes were placed in a Lonza 4D-Nucleofector system and program C2167 (for MEFs) was used. Warm medium (500 l) was added to the cuvette, and cells were transferred to a six-well plate with medium equilibrated at 37C with 5% CO2 using a pipette bulb without pipetting up and down. Cells were selected with puromycin (1 to 2.0 g/ml) 24 hours after transfection for 4 to 6 days.

Single-molecule data were acquired and analyzed as described previously (14). Briefly, data were acquired with excitation with a 532-nm laser at 5 frames/s for 300 or 600 frames and with direct acceptor excitation at 635 nm for approximately 10 frames at roughly frame 100. The direct excitation helped to distinguish between low-FRET sensors and sensors without an acceptor dye.

Traces were analyzed using a custom MATLAB code, and donor and acceptor channels were aligned using a single-molecule high-resolution colocalization map generated by scanning across a field of beads (50). The positions of individual sensors were then detected using a spot-finding algorithm (T. Ursell, Stanford University) and were determined to be colocalized if within two pixels. Intensities were calculated on the basis of an average of 7 7 pixels centered around the detected spot and corrected for spectral bleedthrough.

Intensities for each dye were averaged over manually identified FRETing, non-FRETing, and bleached regions. When the acceptor bleached before the donor, we used the following expression to calculate FRET efficiencyE=(IaIa,back)(IaIa,back)+(IdId,back)=IaIa,backId,0Idwhere Ia is the acceptor intensity during FRET, Ia,back is the acceptor background intensity, Id is the donor intensity during FRET, Id,0 is the donor intensity after acceptor photobleaching, Id,back is the donor background intensity, and is the correction factor accounting for relative dye quantum yields and instrument detection efficiencies.

When the donor fluorophore bleached first, the FRET efficiency was calculated asE=(IaIa,back)(IaIa,back)+0(IdId,back)

Values for 0 were 0.40 for MTSlow, 0.52 for MTSFN, and 0.52 for MTShigh.

Events were double-checked by generating a series of z projections for the donor and acceptor molecule during FRETing, non-FRETing, and bleached states. The autoGaussianSurf Matlab function (P. Mineault) was used to fit a two-dimensional Gaussian to the 7 7pixel area to determine whether the spot represented a single emitting fluorophore. Low-FRET events were verified as having a functional acceptor by direct excitation with a 635-nm laser.

Combined single-molecule histograms for MTSlow and MTShigh were created by normalizing the proportion of molecules for the overlapping force bins. The proportion of molecules greater than 7 pN measured previously using MTSlow nearly matched the proportion of molecules bearing greater than 7 pN measured using MTShigh (14). The final histograms were created by scaling the force distribution measured by MTShigh by the proportion of molecules bearing greater than 7 pN measured using MTSlow for molecules within adhesions, underneath cells, and outside adhesions separately.

The FRET versus force response of the (GPGGA)8 linker used here was previously reported by Grashoff et al., and an updated calibration was recently reported by LaCroix et al. (51, 52). We used the updated MATLAB calibrations from LaCroix et al. to generate improved FRET versus force calibration curves. Using 43 amino acids (for the eight repeats of GPGGA plus the two cysteines and a single lysine), a fluorophore radius of 0.5 nm, a Forster radius of 6.95 nm, and persistence lengths from 0.87 to 0.98 nm, we constructed three FRET-force calibration curves to account for the slightly different resting FRET efficiencies determined experimentally (fig. S11).

Ensemble measurements were performed as previously described (14). In summary, images of eGFP-paxillin marked cells were acquired using a Hamamatsu Orca Flash 4.0 camera and were subsequently corrected for illumination spatial inhomogeneities, background-subtracted, and intensity-normalized. The GFP image was then boxcar-averaged (moving average v3.1 from MATLAB Central File Exchange) at 10 different rotations of the original image at 20 intervals, thresholded, and segmented using a watershed algorithm. The segmented image was then corrected to combine adjacent islands representing a single adhesion and filtered to exclude islands below a lower limit (0.5 m2). The segmented GFP image was then used to mask the corresponding FRET signal.

FRET images were converted to FRET index values by dividing the acceptor intensity over the sum of the donor and the acceptor signal. Then, the FRET images were converted to FRET efficiency after correcting to dye labeling efficiency, bleedthrough, the measured no-load FRET efficiency, and the FRET-index measured outside the cell (14). The total integrated traction of a cell was calculated by summing the force contributions (defined as the average pixel value times number of pixels) for pixels within adhesions. For MTSlow or MTSFN910, forces corresponding to >7pN were set to 7.1 pN. For MTShigh measurements, calculated forces corresponding to <7 pN were set to 0 pN.

Traces with potential dynamic behavior, identified by having distinct anticorrelated signals, were marked and analyzed individually. Step events were classified by having large anticorrelated changes in the donor and acceptor signal within the period of one to three frames (0.2 to 0.6 s) and were manually annotated. Force traces were smoothed using a median filter over five frames. Ramp events were classified by having more gradual anticorrelated changes and were manually marked. Ramp traces were then converted to the force domain, and only changes in load between 2 and 7 pN were fit. Dynamic events were only accepted if the acceptor was confirmed to be active and could not be accounted for by either donor or acceptor photobleaching. Very few dynamic-like sensors were observed under no-load conditions (table S5).

Halo-PEG coverslips were incubated with 100 nM unlabeled RGD sensor at room temperature for 30 min, and cells were seeded and allowed to spread for at least ~1 hour. After a 9-min incubation with 50 nM SiR-actin (Cytoskeleton Inc., no. CY-SC001), the sample was incubated with Prolong Live Antifade Reagent (Invitrogen, P36975) for 1 hour. The low dilution of SiR-actin allowed for individual molecules to be tracked, and the addition of Prolong reduced photobleaching. For each cell, a 100-ms exposure of the GFP-paxillin channel (for masking) was first acquired, followed by a 60-frame sequence in the far red channel (SiR-actin) with 300-ms exposures taken every 2 s.

For fixed cell control data, cells were allowed to spread on functionalized coverslips and then fixed in 4% paraformaldehyde for 15 min at room temperature. After rinsing, the cells were treated with SiR-actin and Prolong reagent as above.

Speckles and tracks were identified using quantitative fluorescent speckle microscopy software made available by the Danuser laboratory (53). The localizations, which are given with pixel precision, are fit to subpixel positions by Gaussian fitting.

Every frame was used to track speckles, but velocities were calculated from speckle displacements over five frames (10 s), giving velocities on the time scale of our FRET measurements. Adhesions were masked by an Otsu threshold of the eGFP-paxillin image after background subtraction to remove the diffuse cytoplasmic signal. F-actin stress fibers were masked as the brightest 3% of pixels of a time-series projection of the F-actin tracks. We measure the actin velocities of tracks that originate both over stress fibers and adhesions.

From our mean velocity measurement, , we calculate a corrected velocity, s, using the following relation (50)s=d242where is the localization error (SD) of single-molecule localizations (estimated to be 47 nm here).

In the reversible cross-linker model, F-actin was treated as a network of filaments connected by noncompliant dynamic cross-linkers (Fig. 4). These cross-linkers bind and unbind at rates kx,on and kx,off. Each clutch is bound to an individual filament, and the number of motors per filament is dictated by simulation parameters (table S6). Force traces were averaged over 1-s time steps to reflect the time scale of the processed force traces from the single-molecule measurement. Individual clutches experience load routed from different combinations of motors at any given instant, where individual loads are dictated by both the force-velocity relationships of individual motors and the loading history of the clutches within the cluster. The forces on individual clutches build until the F-actin retrograde flow rate is close to 0 and the motor stall force and clutch force are nearly equal. When a cross-linker binds or unbinds, the forces on the associated clutches are no longer balanced, and the F-actin velocities adjust to reestablish mechanical equilibrium.

In the resulting simulations, dynamic clusters of clutches continuously stretch and relax, oscillating around force plateaus for periods of 10 to 60 s. Ramp and step transitions are observed throughout these simulations, in a manner consistent with our experimental observation: A step transition occurs when a binding clutch quickly builds force or when an unbinding clutch instantaneously returns to 0 force. More gradual ramp transitions occur in neighboring clutches as the associated loads readjust to achieve a force balance within the cluster.

Although a variety of models were explored, the dynamic F-actin network best captured the behavior observed experimentally. In contrast to the other models, the force plateaus persisted the longest with minimal fluctuations, and the single-clutch dynamics were consistent across simulation parameters (i.e., relatively insensitive to small parameter changes). Although further testing of the dynamic F-actin network model is still needed and alternate models have not been definitively ruled out, the dynamic F-actin model best captures the experimentally observed behavior of the individual sensor force distribution and force dynamics.

Energy dissipation was calculated as the sum of stored energy in anchors upon unbinding. When an unbinding event occurred, the stored energy in the anchor was calculated using the spring constant of the anchor and its displacementE=12kcx2

The running sum of this value was recorded for the duration of the experiment. This does not account for energy dissipation within the motor-actin system.

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license, which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.

Acknowledgments: We thank K. Rothenberg of the Hoffman laboratory (Duke University) for the vin/ MEFs, M. Franklin from the Liphardt laboratory (Stanford University) for the U2OS cells, and R. Fssler (Max Planck Institute, Martinsried) for the pKO cells. We thank the Khosla laboratory for their protein purification expertise and access to their equipment. We would also like to thank A. LaCroix from the Hoffman laboratory (Duke University) for useful discussions on FRET-force calibrations and B. Zhong, E. Korkmazhan, C. Garzon-Coral, W. Weis, and O. Chaudhuri for useful discussions and feedback. The data reported in this paper are further detailed in the Supplementary Materials. Funding: Research reported in this publication was supported by grants R01-CA172986 and U54-CA210190 to D.J.O. and R01-GM112998-01 and R35-GM130332 to A.R.D. from the National Institutes of Health (NIH). The research of A.R.D. was supported, in part, by a Faculty Scholar from the Howard Hughes Medical Institute. S.J.T. was supported by the John Stauffer Stanford Graduate Fellowship from Stanford, and A.C.C., C.M.M., and L.S.P. were supported by Graduate Research Fellowships from the National Science Foundation (00039202). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Author contributions: S.J.T., A.C.C., and C.M.M. performed experiments and analyzed data. S.M.A., L.S.P., and A.R.D. created and ran clutch model simulations. All authors contributed to the writing and editing of the manuscript. Competing interests: The authors declare that they have no competing interests. Data and materials availability: All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. Additional data related to this paper may be requested from the authors.

Originally posted here:
Regulation and dynamics of force transmission at individual cell-matrix adhesion bonds - Science Advances

Cloud Computing in Cell Biology, Genomics and Drug Development Market Analysis by Top Key Players, Considering Growth and Demand with Product Type,…

The Cloud Computing in Cell Biology, Genomics and Drug Development Market report market intelligence study intended to offer complete understanding of global market scenario with the Impact of COVID-19 (Corona Virus). It attempts to analyze the major components of the Market which have greater influence on it. This includes various elements of significant nature including market overview, segmentation, competition landscape, Market chain analysis, key players strategyand more. Also, the report provides a 360-degree overview of global market on the basis of various analysis techniques including SWOT and Porters Five Forces. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. This might help readers to understand the strengths, opportunities, challenges and perceived threats of the market.

The following Companies are coveredin theResearch Report: Amazon Web Services (AWS) Inc., Cisco Systems Inc., DXC Technology, Google LLC, Salesforce.com Inc., and SAP SE

Based on Classification, each type is studied as Sales, Market Share (%), Revenue (Million USD), Price, Gross Margin and more similar information. The report can help to realize the market and strategize for business expansion accordingly. In the strategy analysis, it gives insights from marketing channel and market positioning to potential growth strategies, providing in-depth analysis for new entrants or exists competitors in the Cloud Computing in Cell Biology, Genomics and Drug Development industry.

The Cloud Computing in Cell Biology, Genomics and Drug Development Market report wraps:

There are 13 Chapters to thoroughly display the Cloud Computing in Cell Biology, Genomics and Drug Development market. This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications and regions.

In the end, The objective of the market research report is the current status of the market and in accordance classifies it into a few objects. The report takes into consideration the first market players in every area from over the globe.

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Here is the original post:
Cloud Computing in Cell Biology, Genomics and Drug Development Market Analysis by Top Key Players, Considering Growth and Demand with Product Type,...

Immunai wants to map the entire immune system and raised $20 million in seed funding to do it – TechCrunch

For the past two years the founding team of Immunai had been working stealthily to develop a new technology to map the immune system of any patient.

Founded by Noam Solomon, a Harvard and MIT-educated postdoctoral researcher, and former Palantir engineer, Luis Voloch, Immunai was born from the two mens interest in computational biology and systems engineering. When the two were introduced to Ansuman Satpathy, a professor of cancer immunology at Stanford University, and Danny Wells, who works as a data scientist at the Parker Institute for Cancer Immunotherapy, the path forward for the company became clear.

Together we said we bring the understanding of all the technology and machine learning that needs to be brought into the work and Ansu and Danny bring the single-cell biology, said Solomon.

Now as the company unveils itself and the $20 million in financing it has received from investors including Viola Ventures and TLV Partners, its going to be making a hiring push and expanding its already robust research and development activities.

Immunai already boasts clinical partnerships with over ten medical centers and commercial partnerships with several biopharma companies, according to the company. And the team has already published peer-reviewed work on the origin of tumor-fighting T cells following PD-1 blockade, Immunai said.

We are implementing a complicated engineering pipeline. We wanted to scale to hundreds of patients and thousands of samples, said Wells. Right now, in the world of cancer therapy, there are new drugs coming on the market that are called checkpoint inhibitors. [Were] trying to understand how these molecules are working and find new combinations and new targets. We need to see the immune system in full granularity.

Thats what Immunais combination of hardware and software allows researchers to do, said Wells. Its a vertically integrated platform for single cell profiling, he said. We go even further to figure out what the biology is there and figure that out in a new combination design for the trial.

Cell therapies and cancer immunotherapies are changing the practice of medicine and offering new treatments for conditions, but given how complex the immune system is, the developers of those therapies have few insights into how their treatments will affect the immune system. Given the diversity of individual patients, variations in products can significantly change the way a patient will respond to the treatment, the company said.

Photo: Andrew Brookes/Getty Images

Immunai has the potential to change the way these treatments are developed by using single-cell technologies to profile cells by generating over a terabyte of data from an individual blood sample. The companys proprietary database and machine learnings tools map incoming data to different cell types and create profiles of immune responses based on differentiated elements. Finally, the database of immune profiles supports the discovery of biomarkers that can then be monitored for potential changes.

Our mission is to map the immune system with neural networks and transfer learning techniques informed by deep immunology knowledge, said Voloch, in a statement. We developed the tools and know-how to help every immuno-oncology and cell therapy researcher excel at their job. This helps increase the speed in which drugs are developed and brought to market by elucidating their mechanisms of action and resistance.

Pharmaceutical companies are already aware of the transformational potential of the technology, according to Solomon. The company is already in the process of finalizing a seven-figure contract from a Fortune 100 company, according to Solomon.

One of the companys earliest research coups was using research to show the way that immune systems function when anti-PD1 molecules are introduced. Typically the presence of PD-1 means that T cell production is being suppressed. What the research from Immunai revealed was that the response wasnt happening with T cells within the tumor. There were new T cells that were migrating to the tumor to fight it off, according to Wells.

This whole approach that we have around looking at all of these indications we believe that the right way and most powerful way to study these diseases is to look at the immune system from the top down, said Voloch, in an interview. Looking at all of these different scenarios. From the top, you see these patterns than wouldnt be available otherwise.

See original here:
Immunai wants to map the entire immune system and raised $20 million in seed funding to do it - TechCrunch